Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline.

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline. American journal of preventive cardiology Cardoso, R., Shaw, L. J., Blumenthal, R. S., Nasir, K., Ferraro, R., Maron, D. J., Blaha, M. J., Gulati, M., Bhatt, D. L., Blankstein, R. 2022; 11: 100365

Abstract

A core principle of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline is the importance of preventive therapies among patients with nonobstructive or obstructive coronary artery disease (CAD). Accordingly, this editorial provides unique insights that emphasize the role of preventive cardiology throughout the new guideline. For the first time, CAD was defined to also include nonobstructive plaque. This definition was based on the fact that individuals who have nonobstructive plaque are at an increased risk of atherosclerotic events compared with those who do not. Herein, we highlight guideline recommendations related to the diagnosis and management of nonobstructive CAD. We also highlight recommendations which emphasize the importance of preventive therapies. Adoption of these recommendations have the potential to lead to enhanced preventive therapies and improve patient outcomes.

View details for DOI 10.1016/j.ajpc.2022.100365

View details for PubMedID 35844247